Metallomic profiling and linkage map analysis of early parkinson's disease: A new insight to aluminum marker for the possible diagnosis

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Ahmed, Shiek S S J ^a   Santosh, Winkins ^a  

^a SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; ARSENIC; BARIUM; CADMIUM; CALCIUM; CESIUM; CHROMIUM; COBALT; COPPER; FLUORINE; IODINE; IRON; LEAD; MAGNESIUM; MANGANESE; MERCURY; MOLYBDENUM; NICKEL; PHOSPHORUS; POTASSIUM; RUBIDIUM; SELENIUM; SILICON; SILVER; SODIUM; STRONTIUM; SULFUR; TITANIUM; ZINC;

ADULT; ALUMINUM BLOOD LEVEL; ARTICLE; ARTIFICIAL NEURAL NETWORK; ATOMIC EMISSION SPECTROMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISCRIMINANT ANALYSIS; DISEASE DURATION; DISEASE MARKER; FEMALE; GENETIC LINKAGE; HUMAN; MALE; MASS SPECTROMETRY; PARKINSON DISEASE; TRACE METAL BLOOD LEVEL;

ALUMINUM; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; GENETIC LINKAGE; HUMANS; MASS SPECTROMETRY; PARKINSON DISEASE;

EID: 77955288341     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011252     Document Type: Article

References (51)

1. Guttman M, Kish SJ, Furukawa Y (2003) Current concepts in the diagnosis and management of Parkinson's disease. CMAJ 168: 293-301.
2. Ahmed SSSJ, Santosh W, Kumar S, Christlet HTT (2009) Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection. J Biomed Sci 16: 63.
3. Ahmed SSSJ, Santosh W, Kumar S (2009) Neural network algorithm for the early detection of Parkinson's disease from blood plasma by FTIR microspectroscopy. Vib. Spectrosc In press.
4. Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51: 745-752.
5. Gelb, Oliver, Gilman (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56: 33-39.
6. Strong MJ, Garruto RM (1994) Experimental paradigms of motor neuron degeneration. In: Woodruff ML, Nonneman AJ, eds. Toxin-induced Models of Neurological Disorders. pp 39-88.
7. Garruto RM, Flaten TP, Wakayama I (1993) Natural and experimental models of environmentally induced neurodegeneration: Implication for Alzheimer's disease. In: Corain B, Wisneiwski H, Zatta P, eds. Alzheimer's Disease: Advances in Clinical and Basic Research. pp 257-266.
8. Takuya H, Kazumi I, Hiroki H (2001) Multielement Correlation Analysis of Major-to-Trace Elements in Human Blood Serum for Medical Diagnosis as Studied by ICP-AES and ICP-MS. Anal Sci 17: 979-982.
9. Koichi W, Masayoshi K (2003) Trace Elements in the Environment The Elements Analysis of the Tissue Section of the Lung Disease Caused by Environmental Pollution by Means of Electron Probe Microanalysis. Biomed Res Trace Elem 14: 275-278.
10. Hagve TA, Asberg A, Ulvik R, Borch-Iohnsen B, Thorstensen K (2009) Hemochromatosis from an underdiagnosed curiosity to a common disease. Tidsskr Nor Laegeforen 129: 863-866.
11. Nikolov IG, Mozar A, Drüeke TB, Massy ZA (2009) Impact of disturbances of calcium and phosphate metabolism on vascular calcification and clinical outcomes in patients with chronic kidney disease. Blood Purif 27: 350-359.
12. Hur CI, Yoon TR, Cho SG, Song EK, Seon JK (2008) Serum ion level after metal-on-metal THA in patients with renal failure. Clin Orthop Relat Res 466: 696-699.
13. Park W, Kim BS, Lee JE, Huh JK, Kim BJ, et al. (2009) Serum phosphate levels and the risk of cardiovascular disease and metabolic syndrome: a double-edged sword. Diabetes Res Clin Pract 83: 119-125.
14. Harrison-Findik DD (2009) Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease? World J Gastroenterol 15: 1186-1193.
15. Seiler HG, Sigel A, Sigel H (1994) Overview And use of the hand book. In: Seiler G, Sigel A, Sigel H, eds. Hand book on metals in clinical and analytical chemistry. pp 10.
16. Cuajungco MP, Lees GJ (1997) Zinc and Alzheimer's disease: is there a direct link? Brain Res Brain Res Rev 23: 219-36.
17. Basun H, Forssell LG, Wetterberg L, Winblad B (1991) Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. J Neural Transm Park Dis Dement Sect 4: 231-258.
18. Zecca L, Pietra R, Goj C, Mecacci C, Radice D, et al. (1994) Iron and other metals in neuromelanin, substantia Nigra and Putamen of human brain. J Neurochem 62: 1097-1101.
19. Rao KSJ, Rao RV, Shanmugavelu P, Menon RB (1999) Trace elements in Alzheimer's brain: A new hypothesis. Alz Rep 2: 241-246.
20. Bharathi, Vasudevaraju, Govidaraju, Palanisamy, Sambamurti, et al. (2008) Molecular toxicity of aluminum in relation to neurodegeneration. Indian J Med Res 128: 545-556.
21. Gaeta A, Hider RC (2005) The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br J Pharmacol 146: 1041-1059.
22. Bharathi, Ravid R, Rao KS (2006) Role of Metals in Neuronal Apoptosis: Challenges Associated with Neurodegeneration. Curr Alzheimer Res 3: 311-326.
23. Hegde ML, Shanmugavelu P, Vengamma B, Rao TS, Menon RB, et al. (2004) Serum trace element levels and the complexity of inter-element relations in patients with Parkinson's disease. J Trace Elem Med Biol 18: 163-171.
24. Alimonti A, Ristori G, Giubilei F, Stazi MA, Pino A, et al. (2007) Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis. Neurotoxicology 28: 450-456.
25. Abbot RA, Cox M, Markus H, Tomkins A (1992) Diet, body size and micronutrient status in Parkinson's disease. Eur J Clin Nutr 46: 879-884.
26. Jimenez-Jimenez FJ, Fernandez-Calle P, Martinez-Vanaclocha M, Herrero E, Molina JA, et al. (1992) Serum levels of zinc and copper in patients with Parkinson's disease. J Neurol Sci 112: 30-33.
27. Hasegawa T, Matsuura H, Inagaki K, Haraguchi H (2003) Major-to-ultratrace element in bone marrow fluid as determined and ICP-MS. Anal Sci 19: 147-150.
28. Mustak MS, Rao TS, Shanmugavelu P, Sundar NM, Menon RB, et al. (2008) Assessment of serum macro and trace element homeostasis and the complexity of inter-element relations in bipolar mood disorders. Clin Chim Acta 394: 47-53.
29. Bharathi, Shamasundar NM, Sathyanarayana Rao TS, Dhanunjaya Naidu M, Ravid R, et al. (2006) A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model. Brain Res Rev 52: 275-292.
30. Savory J, Rao JK, Huang Y, Letada PR, Herman MM (1999) Age-related hippocampal changes in Bcl-2:Bax ratio, oxidative stress, redox-active iron and apoptosis associated with aluminum-induced neurodegeneration: increased susceptibility with aging. Neurotoxicology 20: 805-817.
31. Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, et al. (2002) Lipid peroxidation and antioxidant enzyme concentrations in patients with Schizophrenia and bipolar disorder. Cell Biochem Funct 20: 171-175.
32. Kalra J, Rajput AH, Mantha SV, Prasad K (1992) Serum antioxidant enzyme activity in Parkinson's disease. Mol Cell Biochem 110: 165-168.
33. Savory J, Herman MM, Ghribi O (2003) Intracellular mechanisms underlying aluminium-induced apoptosis in rabbit brain. J Inorg Biochem 97: 157-154.
34. Ghribi O, Herman MM, Dewitt DA, Forbes MS, Savory J (2001) A beta (1-42) and aluminium induce stress in the endoplasmic reticulum in rabbit hippocampus, involving nuclear translocation of gadd 153 and NF-kappa B. Brain Res Mol Brain Res 96: 30-38.
35. Olatunbosun DA, Akindele BK, Adadevoh BK, Asuni T (1975) Serum copper in schizophrenia in Nigerians. Br J Psychiatry 127: 119-121.
36. Alias AG, Vijayan N, Nair DS, Sukumaran M (1972) Serum ceruloplasmin in schizophrenia:significant increase in acute cases especially in catatonia. Biol Psychiatry 4: 231-238.
37. Pfeiffer CC, Ilier UA (1972) Study of zinc deficiency and copper excess in the schizophrenias. Int Rev Neurobiol 1: 141-165.
38. Diebel MA, Ehmann WD, Markesbery WR (1996) Copper, iron and zinc imbalances severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J Neurol Sci 143: 137-142.
39. Carri MT, Ferri A, Cozzolino M, Calabrese L, Rotilio G (2003) Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals. Brain Res Bull 61: 365-374.
40. Malecki EA (2001) Manganese toxicity is associated with mitochondrial dysfunction and DNA fragmentation in rat primary striatal neurons. Brain Res Bull 55: 319-325.
41. Huang X, Cuajungco MP, Atwood CS, Hartshorn MA, Tyndall JD, et al. (1999) Cu (II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem 274: 37111-37116.
42. Bush AI, Pettingell WH, Multhaup G, deParadis M, Vonsattel JP, et al. (1994) Rapid induction of Alzheimer Abeta amyloid formation by zinc. Science 265: 1464-1467.
43. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NM, et al. (1998) Dramatic aggregation of Alzheimer Ab by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem 273: 12817-12826.
44. Bush AI, Multhaup G, Moir RD, Williamson TG, Small DH, et al. (1993) A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease. J Biol Chem 268: 16109-161112.
45. Savory J, Rao JK, Huang Y, Letada PR, Herman MM (1999) Age-related hippocampal changes in Bcl-2: Bax ratio, oxidative stress, redox-active iron and apoptosis associated with aluminum-induced neurodegeneration: increased susceptibility with aging. Neurotoxicology 20: 805-817.
46. Youdim MBH, Yehuda, Ben-Shackar D, Ashkenazi R (1982) Behavioral and brain biochemical changes in iron deficient rats: the involvement of iron in dopamine receptor function. In: Pollitt E, Leibel RL, eds. Iron deficiency: brain biochemistry and behavior. pp 39-56.
47. O'Keeffe GC, Michell AW, Barker RA (2009) Biomarkers in Huntington's and Parkinson's Disease. Ann N Y Acad Sci, 1180: 97-110.
48. Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J (2004) Are men at greater risk for Parkinson's disease than women?. J Neurol Neurosurg Psychiatry 75: 637-639.
49. Haaxma CA, Bloem BR, Borm GF, Oyen WJ, Leenders KL, et al. (2007) Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry 78: 818-824.
50. National Committee for Clinical Laboratory Standards Approved Guidelines. Available: http://www.clsi.org/source/orders/free/c38-a.
51. Gillian L, Jack DF, Benjamin G, David EN, Patrick JP, et al. (1997) Control of pre-analytical variation in trace element determination. National committee for Clinical Laboratory Standards Approved guidelines 17: 1-30.